0.35Open0.35Pre Close0 Volume100 Open Interest6.00Strike Price0.00Turnover67.18%IV8.58%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type-0.3931Delta0.3410Gamma17.66Leverage Ratio-0.0078Theta-0.0018Rho-6.94Eff Leverage0.0065Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet